The biotech bi-weekly: redefining molecular precision with circular dichroism microspectroscopy and enhancing in silico drug discovery
Check out the latest biotech industry news, from a groundbreaking analytical tool providing unparalleled insights into molecular structures and interactions on the nanoscale to company partnerships accelerating the discovery of novel molecules.
Products
CRAIC Technologies’ circular dichroism microspectrometers redefine molecular precision
CRAIC Technologies (CA, USA), a leading provider of innovative spectroscopic solutions, has recently introduced circular dichroism microspectroscopy to its range of optical tools. In the dynamic realm of nanotechnology, circular dichroism microspectroscopy has emerged as a groundbreaking analytical tool, enabling unparalleled insights into the molecular structures and interactions that drive innovation at the nanoscale.
By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is transforming the design and understanding of nanoscale materials and devices, including providing molecular insights into the characterization of nanocarriers, which is accelerating innovations in targeted therapeutics.
Read more about their technology here >>>
Virtual Science AI unveils real-time intelligent Q&A feature for life science insights
Virtual Science AI (London, UK) has established itself as a trusted partner for life science teams. Using its proprietary insight management and advisory panel solutions, it transforms complex scientific data analysis into clear strategic insights.
Building on their solid foundation, Virtual Science AI recently introduced a new intelligent strategic real-time Q&A search function. This new, enhanced Q&A search capability delivers real-time summaries for data queries in seconds, helping life science teams make faster, more informed decisions.
Read the full release here >>>
Bio-Rad launches TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits for antibody conjugation to StarBright Dyes
Bio-Rad Laboratories, Inc. (CA, USA), a global leader in life science research and clinical diagnostics products, announced the launch of its TrailBlazer™ Tag and TrailBlazer StarBright™ Dye Label Kits. The new kits offer a convenient method to label any antibody with one of Bio-Rad’s StarBright Dyes, for use in either flow cytometry or fluorescent western blot experiments.
Read the full release here >>>
ChromoGen: the AI tool predicting 3D genomic structures in minutes
A novel, freely available AI tool has cut the time it takes to determine chromatin structure from days to minutes.
Partnerships and publications
New preeclampsia research funded to investigate genetic targets to develop potential therapeutics
The Preeclampsia Foundation (FL, USA) announced the recipients of its 2025 Peter Joseph Pappas Research Grants. Based on the recommendations of its Scientific Advisory Council, the Preeclampsia Foundation awarded two grants totaling US$99,997 each to Zsuzsanna Zsengellér – for her work developing novel small molecule therapeutics for the treatment of preeclampsia – and Virginia Winn – for her work harnessing paired maternal–child induced pluripotent stem cells to model preeclampsia.
Read the full release here >>>
Antibodies.com and Cactus Communications partner to accelerate life science manuscript publication
Antibodies.com (Cambridge, UK), a trusted provider of high-quality biological reagents for life science researchers, and Cactus Communications (Mumbai, India), a global leader in science communication and technology, announced a partnership to support effective science communications. The collaboration aims to simplify the journey from discovery to publication by providing essential tools for high-quality, impactful research, driving innovation and accelerating advancements in the life sciences.
Read the full release here >>>
Schrödinger selects Sapio Sciences to enhance in silico drug discovery
Sapio Sciences (MD, USA), the science-aware™ lab informatics platform, announced that Schrödinger (NY, USA), a global leader in computational chemistry, has adopted the Sapio Platform to improve data management, enhance lab efficiency and accelerate the discovery of novel molecules. By deploying Sapio’s unified informatics platform, including Sapio LIMS and Sapio ELN, Schrödinger is transforming its recently acquired wet lab operations, integrating data, and streamlining workflows.
Read the full release here >>>
The biotech bi-weekly: 29 January 2025
Biotech industry news: from hydrogels supporting patient-derived xenograft studies and NGS panels capable of detecting MRD, to a generative AI platform for biology and chemistry and expansion of sample storage for biomedical research.
People
Glox Therapeutics strengthens team, appointing Michael Murray as Chair and Nel Moore as Scientific Advisory Board member
Glox Therapeutics (Glasgow, UK), a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced the appointment of Michael Murray as Chair of the Board. He will work with the team to accelerate the company’s growth and help guide the commercialization of its technology. The company has also expanded its scientific advisory board, adding Nel Moore to support the development of its novel engineered protein bacteriocins to target drug-resistant pathogenic bacteria and help overcome antimicrobial resistance.
Read the full release here >>>
Touchlight appoints industry leader Will Downie as adviser to support strategic growth in synthetic DNA platforms
Touchlight (London, UK), a pioneering leader in synthetic DNA technology, has announced the appointment of Will Downie as a key adviser to support its mission in advancing genetic medicines. Downie’s extensive experience as an industry leader delivering strategic business growth across pharmaceutical services and product development positions him as a valuable contributor in further driving Touchlight’s synthetic DNA platforms forward.
Read the full release here >>>
Azenta announces the election of Dipal Doshi to its Board of Directors
Biotech company Azenta, Inc. (MA, USA) has announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (MA, USA) and a recognized leader in the biotechnology and pharmaceutical industries, has been elected to its Board of Directors at its Annual Meeting of Stockholders held on 30 January 2025.
“Mr. Doshi is an extraordinary leader who brings significant experience in the biotechnology and pharmaceutical industries,” commented John Marotta, President and CEO of Azenta. “His experience in strategy, operational and commercial growth, and perspective as a current public company CEO make him a perfect fit for our Board.
Read the full release here >>>
Vect-Horus further strengthens leadership with appointment of strategy and finance executive Jérôme Berger to its Board of Directors
Vect-Horus (Marseille, France), a privately held biotechnology company that designs and develops molecular vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, recently announced the appointment of Jérôme Berger as a member of its Board of Directors. Berger’s vast expertise in strategy, finance and venture capital in the technology and life sciences sectors will be invaluable to Vect-Horus as the company accelerates its growth and development.
